SCID-X1: lentiviral Gene Therapy plus Busulfan

被引：0
|
作者：
Krome, Susanne
机构：
来源：
TRANSFUSIONSMEDIZIN | 2019年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Lentiviral gene therapy with busulfan conditioning for older patients with SCID-X1
    De Ravin, S. S.
    Sorrentino, B. P.
    Malech, H. L.
    HUMAN GENE THERAPY, 2016, 27 (11) : A37 - A37
  • [2] Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
    Mamcarz, Ewelina
    Zhou, Sheng
    Lockey, Timothy
    Abdelsamed, Hossam
    Cross, Shane J.
    Kang, Guolian
    Ma, Zhijun
    Condori, Jose
    Dowdy, Jola
    Triplett, Brandon
    Li, Chen
    Maron, Gabriela
    Aldave Becerra, Juan C.
    Church, Joseph A.
    Dokmeci, Elif
    Love, James T.
    da Matta Ain, Ana C.
    van der Watt, Hedi
    Tang, Xing
    Janssen, William
    Ryu, Byoung Y.
    De Ravin, Suk See
    Weiss, Mitchell J.
    Youngblood, Benjamin
    Long-Boyle, Janel R.
    Gottschalk, Stephen
    Meagher, Michael M.
    Malech, Harry L.
    Puck, Jennifer M.
    Cowan, Morton J.
    Sorrentino, Brian P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (16): : 1525 - 1534
  • [3] Integrome signatures of lentiviral gene therapy for SCID-X1 patients
    Yan, Koon-Kiu
    Condori, Jose
    Ma, Zhijun
    Metais, Jean-Yves
    Ju, Bensheng
    Ding, Liang
    Dhungana, Yogesh
    Palmer, Lance E.
    Langfitt, Deanna M.
    Ferrara, Francesca
    Throm, Robert
    Shi, Hao
    Risch, Isabel
    Bhatara, Sheetal
    Shaner, Bridget
    Lockey, Timothy D.
    Talleur, Aimee C.
    Easton, John
    Meagher, Michael M.
    Puck, Jennifer M.
    Cowan, Morton J.
    Zhou, Sheng
    Mamcarz, Ewelina
    Gottschalk, Stephen
    Yu, Jiyang
    SCIENCE ADVANCES, 2023, 9 (40)
  • [4] Development of a Clinical Lentiviral Vector for Gene Therapy of SCID-X1
    Charrier, Sabine
    Poletti, Valentina
    Martin, Samia
    Gjata, Bernard
    Hebben, Matthias
    Vignaud, Alban
    Zhang, Fang
    Buckland, Karen
    Rothe, Michael
    Schambach, Axel
    Gaspar, Bobby
    Thrasher, Adrian
    Mavilio, Fulvio
    MOLECULAR THERAPY, 2016, 24 : S273 - S274
  • [5] Gene therapy of SCID-X1
    Baum, C.
    Schambach, A.
    Modlich, U.
    Thrasher, A.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2007, 50 (12) : 1507 - 1517
  • [6] Pre-clinical development of lentiviral gene therapy for SCID-X1
    Charrier, S.
    Poletti, V.
    Martin, S.
    Vignaud, A.
    Hebben, M.
    Zhang, F.
    Buckland, K.
    Rothe, M.
    Schambach, A.
    Gaspar, B.
    Thrasher, A.
    Mavilio, F.
    HUMAN GENE THERAPY, 2015, 26 (10) : A60 - A60
  • [7] Gene therapy for SCID-X1
    Cavazzana-Calvo, Marina
    Hacein-Bey-Abina, Salima
    Garrigue, A.
    Hauer, J.
    Bokhardt, A.
    Soulier, J.
    Delabesse, E.
    Macintyre, E.
    Radford, I.
    Romana, P.
    Wang, G.
    Bushman, F.
    Fischer, Alain
    HUMAN GENE THERAPY, 2007, 18 (10) : 944 - 944
  • [8] Promoter Competition for Gene Therapy of SCID-X1
    Baum, Christopher
    Schambach, Axel
    HUMAN GENE THERAPY, 2011, 22 (03) : 255 - 256
  • [9] Ten years of gene therapy for SCID-X1
    Hacein-Bey-Abina, Salima
    Fischer, Alain
    Cavazzana-Calvo, Marina
    HUMAN GENE THERAPY, 2011, 22 (06) : A7 - A7
  • [10] Gentherapie der SCID-X1Gene therapy of SCID-X1
    Christopher Baum
    A. Schambach
    U. Modlich
    A. Thrasher
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2007, 50 : 1507 - 1517
12345